Finance

Beta
Lists
VULC3:BVMF
Vulcabras SA
R$14.41
-3.22%
(-0.48) 1D
Jun 3, 5:04:00 PM GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for VULC3...
Open
R$14.80
High
R$14.96
Low
R$14.28
Mkt. cap
4.56B
Avg. vol.
1.35M
Volume
1.38M
Dividend
35.52%
Quarterly dividend
R$1.28
Ex-dividend date
Dec 23, 2025
P/E ratio
3.54
52-wk high
R$20.23
52-wk low
R$13.72
EPS
R$4.07
Shares outstanding
317.98M
No. of employees
24K
Open
R$14.80
High
R$14.96
Low
R$14.28
Mkt. cap
4.56B
Avg. vol.
1.35M
Volume
1.38M
Dividend
35.52%
Quarterly dividend
R$1.28
Ex-dividend date
Dec 23, 2025
P/E ratio
3.54
52-wk high
R$20.23
52-wk low
R$13.72
EPS
R$4.07
Shares outstanding
317.98M
No. of employees
24K
News stories
From sources across the web
Profile
Vulcabrasǀazaleia is a Brazilian footwear company, being the third largest in domestic market and in Latin America, only after Brazilians Alpargatas and Grendene. The company was founded in 1952 in São Paulo, but currently is headquartered in Jundiaí. The company is owned by Grendene family, that owns Grendene, the second largest footwear company in Brazil and a competitor of Vulcabrasǀazaleia. The company has 25 plants located in the Brazilian states of Ceará, Sergipe, Bahia, Rio Grande do Sul, and a plant in Argentina and has operations in Argentina, Chile, Uruguay, Colombia, Peru, India and United States. Currently the company operates through its 6 brands that are azaleia, dijean, Olympikus, Opanka, Reebok and Botas Vulcabras. Wikipedia
About Vulcabras SA
CEOPedro Bartelle
Employees23.9K
Founded1952
HeadquartersJundiaí, São Paulo, Brazil
SectorFootwear
Websitevulcabrasri.com
Last report
May 6, 2026
Fiscal period
Q1 2026
EPS / Est. (BRL)
R$0.27 / R$0.28
-0.35%miss
Revenue / Est. (BRL)
776.38M / 784.07M
-0.98%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in BRL
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in BRL
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
894.81M
955.68M
1.01B
776.38M
Cost of goods sold
529.41M
559.84M
590.72M
462.84M
Cost of revenue
529.41M
559.84M
590.72M
462.84M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
218.53M
220.92M
234.85M
194.14M
Operating expense
101.04M
205.17M
238.20M
197.58M
Total operating expenses
630.45M
765.02M
828.92M
660.42M
Operating income
264.36M
190.66M
179.69M
115.96M
Other non operating income
-
-
367.00K
22.28M
EBT including unusual items
383.08M
192.34M
166.60M
89.47M
EBT excluding unusual items
383.08M
192.34M
160.85M
89.47M
Income tax expense
29.81M
-354.83M
7.78M
9.33M
Effective tax rate
7.78%
-184.47%
4.67%
10.43%
Other operating expenses
-115.77M
-16.09M
2.07M
1.58M
Net income
353.28M
547.17M
158.79M
80.13M
Net profit margin
39.48%
57.25%
15.74%
10.32%
Earnings per share
-
0.60
0.58
0.27
Interest and investment income
146.06M
40.79M
19.27M
-
Interest expense
-26.73M
-40.98M
-37.44M
-50.11M
Net interest expenses
119.33M
-182.00K
-18.17M
-50.11M
Depreciation and amortization charges
-
-
-
-
EBITDA
297.04M
212.32M
208.89M
149.63M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer